A randomized study comparing outcome of gestational diabetes mellitus treatment by telemedicine versus routine treatment

Phase 1

Recruiting

• Conditions: gestational diabetes mellitus; Telemedicine; Routine care; REMI application

• Registration Number: TCTR20231014002
• Lead Sponsor: Internal Medicine, Faculty of Medicine, Thammasat University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-10-14
• Study Completion: 2024-03-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

1. Gestational diabetes mellitus patients
2. Aged more than 18 years old
3. Thai
4. Able to read and write in Thai language
5. Having smart phone for use application Line and internet
6. Delivery in Thammasat hospital

Exclusion Criteria

1. Having underlying disease such as Hypertension, Heart disease, liver disease, chronic kidney disease, and HIV infection
2. Receiving medicine that affects blood sugar level such as steroid use

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood glucose for fasting, 1 hour postprandial, 2 hours postprandial 6 months Mean and S.D. of Blood glucose for fasting, 1 hour postprandial, 2 hours postprandial

Secondary Outcome Measures

Name	Time	Method
Maternal and neonatal complications 6 months Percentage of Maternal and neonatal complications